MedTrace Logo

Real Life Effectiveness of Easyhaler (Orion)

NCT02048930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24003

Last updated 2014-01-29

No results posted yet for this study

Summary

The aim of this study is to compare the clinical effectiveness and cost-effectiveness of the Easyhaler® (EH) device and other DPI devices commonly used in the UK in a UK primary care asthma population of patients aged 6 to 80 years.

Conditions

Interventions

DEVICE

Budesonide Easyhaler

DEVICE

Budesonide dry powder inhaler

Sponsors & Collaborators

  • Orion Corporation, Orion Pharma

    collaborator INDUSTRY

  • Research in Real-Life Ltd

    lead NETWORK

Principal Investigators

  • David Price · Research in real life

Eligibility

Min Age
6 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02048930 on ClinicalTrials.gov